Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer

Clinical trial NCT01091428 · COMPLETED

Trial details

NCT number: NCT01091428
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Carcinoma Fallopian Tube Cancer Peritoneal Cancer Breast Carcinoma

Start date: 2010-04-16
Primary completion: 2014-08-12
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.